Anastrozole: repurposed drug could prevent thousands of breast cancer cases
News article discusses anastrozole approval to prevent breast cancer, noting that it is the first drug to be repurposed through the multiagency medicines repurposing programme (launched 2021). Impact is expected to be significant, with 2000 cases prevented and £15 million saved.
Source:
British Medical Journal
SPS commentary:
Anastrozole is now authorised by the MHRA for prevention in post-menopausal women at moderate or high risk of developing breast cancer. This is in addition to its current indication in the treatment of breast cancer in post-menopausal women.